A detailed history of Klr Investment Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Klr Investment Advisors, LLC holds 3,490 shares of ABT stock, worth $407,632. This represents 0.27% of its overall portfolio holdings.

Number of Shares
3,490
Previous 3,851 9.37%
Holding current value
$407,632
Previous $424 Million 11.4%
% of portfolio
0.27%
Previous 0.31%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$109.52 - $120.96 $39,536 - $43,666
-361 Reduced 9.37%
3,490 $376 Million
Q4 2023

Feb 08, 2024

BUY
$90.19 - $110.4 $11,544 - $14,131
128 Added 3.44%
3,851 $424 Million
Q3 2023

Nov 08, 2023

SELL
$95.53 - $114.62 $28,372 - $34,042
-297 Reduced 7.39%
3,723 $377 Million
Q2 2023

Aug 08, 2023

BUY
$100.78 - $112.29 $10,078 - $11,229
100 Added 2.55%
4,020 $438 Million
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $3,099 - $3,648
-32 Reduced 0.81%
3,920 $397 Million
Q4 2022

May 15, 2023

BUY
$95.06 - $111.52 $375,677 - $440,727
3,952 New
3,952 $434 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Klr Investment Advisors, LLC Portfolio

Follow Klr Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klr Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Klr Investment Advisors, LLC with notifications on news.